Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$21.87
+1.5%
$20.38
$17.86
$29.62
$1.07B1.97397,734 shs46,844 shs
CONMED Corporation stock logo
CNMD
CONMED
$37.17
+1.5%
$38.46
$33.21
$61.08
$1.12B0.94510,664 shs47,211 shs
iRadimed Corporation stock logo
IRMD
iRadimed
$85.93
+0.1%
$96.34
$50.61
$107.90
$1.10B0.986,894 shs6,046 shs
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
$4.57
-1.0%
$4.39
$3.42
$7.95
$279.33M0.56164,969 shs6,295 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
+1.60%+3.11%+10.46%-4.94%-10.95%
CONMED Corporation stock logo
CNMD
CONMED
-0.32%-0.58%+5.23%-8.40%-35.71%
iRadimed Corporation stock logo
IRMD
iRadimed
-1.48%+1.62%-10.78%-8.51%+64.17%
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
+5.01%+2.67%+8.73%-6.11%-9.96%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$21.87
+1.5%
$20.38
$17.86
$29.62
$1.07B1.97397,734 shs46,844 shs
CONMED Corporation stock logo
CNMD
CONMED
$37.17
+1.5%
$38.46
$33.21
$61.08
$1.12B0.94510,664 shs47,211 shs
iRadimed Corporation stock logo
IRMD
iRadimed
$85.93
+0.1%
$96.34
$50.61
$107.90
$1.10B0.986,894 shs6,046 shs
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
$4.57
-1.0%
$4.39
$3.42
$7.95
$279.33M0.56164,969 shs6,295 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
+1.60%+3.11%+10.46%-4.94%-10.95%
CONMED Corporation stock logo
CNMD
CONMED
-0.32%-0.58%+5.23%-8.40%-35.71%
iRadimed Corporation stock logo
IRMD
iRadimed
-1.48%+1.62%-10.78%-8.51%+64.17%
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
+5.01%+2.67%+8.73%-6.11%-9.96%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.80
Moderate Buy$32.0046.31% Upside
CONMED Corporation stock logo
CNMD
CONMED
1.86
Reduce$46.2024.28% Upside
iRadimed Corporation stock logo
IRMD
iRadimed
3.00
Buy$120.0039.65% Upside
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
2.00
Hold$7.0053.34% Upside

Current Analyst Ratings Breakdown

Latest TLSI, CNMD, IRMD, and BLFS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2026
CONMED Corporation stock logo
CNMD
CONMED
Lower Price TargetEqual Weight$42.00 ➝ $39.00
4/30/2026
CONMED Corporation stock logo
CNMD
CONMED
Lower Price TargetNeutral$43.00 ➝ $40.00
4/20/2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
Reiterated RatingSell (D-)
4/10/2026
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
Reiterated RatingSell (D-)
4/2/2026
iRadimed Corporation stock logo
IRMD
iRadimed
UpgradeStrong-Buy
3/18/2026
CONMED Corporation stock logo
CNMD
CONMED
UpgradeHold
3/17/2026
CONMED Corporation stock logo
CNMD
CONMED
DowngradeOverweightNeutral$55.00 ➝ $39.00
3/6/2026
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
Lower Price TargetBuy$12.00 ➝ $7.00
2/11/2026
iRadimed Corporation stock logo
IRMD
iRadimed
Reiterated RatingBuy$120.00
2/10/2026
iRadimed Corporation stock logo
IRMD
iRadimed
Reiterated RatingBuy$120.00
(Data available from 5/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$96.21M11.12$0.24 per share92.10$7.72 per share2.83
CONMED Corporation stock logo
CNMD
CONMED
$1.37B0.81$7.46 per share4.98$33.80 per share1.10
iRadimed Corporation stock logo
IRMD
iRadimed
$83.81M13.10$1.88 per share45.69$7.71 per share11.15
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
$45.15M6.20N/AN/A($0.68) per share-6.71
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$4.59M-$0.11N/A87.48N/A-4.50%1.71%1.54%5/7/2026 (Estimated)
CONMED Corporation stock logo
CNMD
CONMED
$47.06M$1.7720.987.631.614.00%13.84%6.05%N/A
iRadimed Corporation stock logo
IRMD
iRadimed
$22.48M$1.8346.9039.78N/A27.36%24.48%21.25%N/A
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
-$39.23M-$1.83N/AN/AN/A-86.88%N/A-94.43%5/12/2026 (Estimated)

Latest TLSI, CNMD, IRMD, and BLFS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2026Q1 2026
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
-$0.16N/AN/AN/A$10.44 millionN/A
5/7/2026Q1 2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$0.01N/AN/AN/A$25.66 millionN/A
5/1/2026Q1 2026
iRadimed Corporation stock logo
IRMD
iRadimed
$0.46$0.49+$0.03$0.45$21.32 million$21.98 million
4/29/2026Q1 2026
CONMED Corporation stock logo
CNMD
CONMED
$0.82$0.89+$0.07$0.45$310.64 million$317.05 million
3/5/2026Q4 2025
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
-$0.13-$0.12+$0.01-$0.21$13.20 million$13.21 million
2/10/2026Q4 2025
iRadimed Corporation stock logo
IRMD
iRadimed
$0.49$0.54+$0.05$0.50$21.60 million$22.69 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/AN/AN/AN/AN/A
CONMED Corporation stock logo
CNMD
CONMED
N/AN/A-5.59%N/AN/A
iRadimed Corporation stock logo
IRMD
iRadimed
$0.800.93%N/A43.72%1 Years
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
N/AN/AN/AN/AN/A

Latest TLSI, CNMD, IRMD, and BLFS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/30/2026
iRadimed Corporation stock logo
IRMD
iRadimed
quarterly$0.200.92%5/15/20265/15/20265/29/2026
2/9/2026
iRadimed Corporation stock logo
IRMD
iRadimed
quarterly$0.200.79%2/23/20262/23/20263/6/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/A
5.94
4.63
CONMED Corporation stock logo
CNMD
CONMED
0.85
2.29
1.04
iRadimed Corporation stock logo
IRMD
iRadimed
N/A
7.13
6.84
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
N/A
2.80
2.54

Institutional Ownership

CompanyInstitutional Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
93.24%
CONMED Corporation stock logo
CNMD
CONMED
N/A
iRadimed Corporation stock logo
IRMD
iRadimed
92.34%
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
2.58%

Insider Ownership

CompanyInsider Ownership
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.20%
CONMED Corporation stock logo
CNMD
CONMED
0.28%
iRadimed Corporation stock logo
IRMD
iRadimed
36.80%
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
16.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
44048.90 million47.82 millionOptionable
CONMED Corporation stock logo
CNMD
CONMED
3,90030.11 million30.06 millionOptionable
iRadimed Corporation stock logo
IRMD
iRadimed
11012.78 million8.08 millionOptionable
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
10661.31 million51.31 millionNot Optionable

Recent News About These Companies

TriSalus (TLSI) Q4 2025 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

BioLife Solutions stock logo

BioLife Solutions NASDAQ:BLFS

$21.87 +0.32 (+1.49%)
As of 10:59 AM Eastern
This is a fair market value price provided by Massive. Learn more.

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

CONMED stock logo

CONMED NYSE:CNMD

$37.17 +0.53 (+1.46%)
As of 10:58 AM Eastern
This is a fair market value price provided by Massive. Learn more.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

iRadimed stock logo

iRadimed NASDAQ:IRMD

$85.93 +0.07 (+0.08%)
As of 10:57 AM Eastern
This is a fair market value price provided by Massive. Learn more.

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

TriSalus Life Sciences stock logo

TriSalus Life Sciences NASDAQ:TLSI

$4.57 -0.05 (-0.98%)
As of 10:57 AM Eastern
This is a fair market value price provided by Massive. Learn more.

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.